Pancreatic weakness in Zucker Fatty rats, a genetic obese model

Journal of Animal and Veterinary Advances

Volumn 9, Issue 23, 2010, Pages 2963-2968

  Ohta, Takeshi ^a,c   Miyajima, Katsuhiro ^b   Yamada, Takahisa ^a,c  

^a KYOTO UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Diabetes; Dysfunction; Pancreas; Streptozotocin; Weakness; ZF rat

Indexed keywords

EID: 78649768490     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2010.2963.2968     Document Type: Article

References (22)

1. Chan, C.B., J.M. Lowe and W.J. Debertin, 1996. Modulation by glucose of insulin secretion and glucose phosphorylating activity in cultured pancreatic islets from obese (fa/fa) Zucker rats. Int. J. Obes. Relat. Metab. Disord., 20: 175-184.
2. De Souza, C.J., J.H. Yu, D.D. Robinson, R.G. Ulnch and M.D. Meglasson, 1995. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance. Diabetes, 44: 984-991.
3. Fernandez-Alvarez, J., A. Barbera, B. Nadal, S. Barcelo-Batllori and S. Piquer et al, 2004. Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate. Diabetologia, 47: 470-477.
4. Finegood, D.T., M.D. McArfhur, D. Kojwang, M.J. Thomas, B.G. Topp, T. Leonard and R.E. Buckingham, 2001. Â-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes, 50: 1021 -1029.
5. Goh, T.T., T.M. Mason, N. Gupta, A. So and T.K.T. Lam et at, 2007. Lipid-induced â-cell dysfunction in vivo in models of progressive â-cell failure. Am. J. Physiol. Endocrinol. Metab., 292: E549-E560.
6. Goran, M.I., C. Lane, C. Toledo-Corral and M.J. Weigensberg, 2008. Persistence of pre-diabetes in overweight and obese Hispanic children: Association with progressive insulin resistance, poor beta-cell function and increasing visceral fat. Diabetes, 57: 3007-3012.
7. Hiramatsu, S., K. Inoue, Y. Sako, F. Umeda and H. Nawata, 1995. Secretion of insulin and glucagon by the perfused pancreas of genetically obese (fa/fa) Zucker rats and its alteration with aging. Endocr. J., 42: 563-567.
8. Hirose, H., Y.H. Lee, L.R Inman, Y. Nagasawa, J.H. Johnson and R.H. "Unger, 1996. Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J. Biol. Chem., 271: 5633-5637.
9. Holman, R.R., 1998. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diab. Res. Clin Pract, 40: S21-S25.
10. Ikeda, H., A. Shino, T. Matsuo, H. Iwatsuka and Z. Suzuoki, 1981. A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes, 30: 1045-1050.
11. Inoescu, E., J.F. Sauter and B. Jeanrenaud, 1985. Abnormal oral glucose tolerance in genetically obese (fa/fa) rats. Am. J. Physiol. Endocrinol. Metab., 248: E500-E506.
12. Jia, D., M. Yamamoto, M. Otani and M. Otsuki, 2004. Bezafibrate on lipids and glucose metabolism in obese diabetic otsuka long-evans Tokushima fatty rats. Metabolism, 53: 405-413.
13. Lee, Y., H. Hirose, M. Ohneda, J.H. Johnson, J.D. McGarry and R.H. Unger, 1994. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-beta-cell relationships. Proc. Natl. Acad. Sci., 91: 10878-10882.
14. Leung, N., T. Sakaue, A. Carpentier, K. Uffelman, A. Giacca and G.F. Lewis, 2004. Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia, 47: 204-213.
15. Mori, Y., J. Yokoyama, M. Nemoto, S. Katoh, M. Nishimura and Y. Ikeda, 1992. Characterization of a new genetically obese-hyperglycemic OLETF rat. Jikeikai Med. J., 39: 349-359.
16. Movassat, J., C. Saulnier, P. Serradas and B. Portha, 1997. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GKrat. Diabetologia, 40: 916-925.
17. Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res., 50: 537-546.
18. Szoke, E., M.Z. Shrayyef, S. Messing, H.J. Woerle and T.W. van Haeften et at, 2008. Effect of aging on glucose homeostasis: Accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care, 31: 539-543.
19. Upton, R., P.S. Widdowson, S. Ishii, H. Tanaka and G. Williams, 1998. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker diabetic fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Br. J. Pharmacol., 125: 1708-1714.
20. Weyer, C, C. Bogardus, D.M. Mott and R.E. Pratley, 1999. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest, 104: 787-794.
21. Weyer, C, R.L. Hanson, P.A. Tataranni, C. Bogardus and R.E. Pratley, 2000. A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: Evidence for a pathogenic role of relative hyperinsulinemia. Diabetes, 49: 2094-2101.
22. Xu, L., CD. Man, B. Charbonnel, G. Meninger and M.J. Davies et al., 2008. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: A model-based approach. Diabetes Obes.Metab., 10: 1212-1220.